---
$id: https://graph.org.ai/products/commodity/51111735
$type: Product
source: UNSPSC
code: "51111735"
title: "Cemadotin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cemadotin

**UNSPSC Code**: 51111735
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca-site binding agent with the molecular formula C35H56N6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6SQ8M7ZSFV, chemically known as l-prolinamide, n,n-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-n-(phenylmethyl)- but generally known as cemadotin, which bears US NIH Compound Identifier 178028. European Medicines Agency schedules Cemadotin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07438MIG. The term CEMADOTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). CEMADOTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cemadotin under HS 29339990 and SITC 51577. As of Q4 2014, CEMADOTIN remains the US FDA Preferred Term for this commodity. Cemadotin bears US NLM identifiers UMLS ID C0754175 and NCI Concept Code C75875. SMILES: O=C(N(C(=O)C1N(CCC1)CC1CCCCC1)C(=O)C(NC(=O)C(N(C)C)C(C)C)C(C)C)C1N(CCC1)C(=O)C(NC)C(C)C.

